ALPS Group, Inc. (ALPS)
0.385
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
ALPS Group Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 69.62M |
| September 08, 2026 | 69.62M |
| September 04, 2026 | 68.79M |
| September 03, 2026 | 68.79M |
| September 02, 2026 | 68.79M |
| September 01, 2026 | 70.37M |
| August 31, 2026 | 70.44M |
| August 28, 2026 | 69.60M |
| August 27, 2026 | 73.77M |
| August 26, 2026 | 75.43M |
| August 25, 2026 | 57.94M |
| August 24, 2026 | 57.97M |
| August 21, 2026 | 58.80M |
| August 20, 2026 | 50.48M |
| August 19, 2026 | 50.48M |
| August 18, 2026 | 54.74M |
| August 17, 2026 | 58.84M |
| August 14, 2026 | 58.80M |
| August 13, 2026 | 60.14M |
| August 12, 2026 | 65.13M |
| August 11, 2026 | 72.95M |
| August 10, 2026 | 74.95M |
| August 07, 2026 | 74.63M |
| August 06, 2026 | 74.61M |
| August 05, 2026 | 72.53M |
| Date | Value |
|---|---|
| August 04, 2026 | 71.52M |
| August 03, 2026 | 71.60M |
| July 31, 2026 | 73.82M |
| July 30, 2026 | 80.90M |
| July 29, 2026 | 78.77M |
| July 28, 2026 | 83.00M |
| July 27, 2026 | 83.37M |
| July 24, 2026 | 83.13M |
| July 23, 2026 | 83.98M |
| July 22, 2026 | 84.76M |
| July 21, 2026 | 85.10M |
| July 20, 2026 | 84.16M |
| July 17, 2026 | 88.76M |
| July 16, 2026 | 79.60M |
| July 15, 2026 | 85.10M |
| July 14, 2026 | 85.00M |
| July 13, 2026 | 88.94M |
| July 10, 2026 | 97.29M |
| July 09, 2026 | 100.40M |
| July 08, 2026 | 102.32M |
| July 07, 2026 | 103.70M |
| July 06, 2026 | 102.62M |
| July 02, 2026 | 103.57M |
| July 01, 2026 | 102.57M |
| June 30, 2026 | 102.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bio Green Med Solution, Inc. | 1.872M |
| ACADIA Pharmaceuticals, Inc. | 3.882B |
| Agenus, Inc. | 557.00M |
| Alkermes Plc | 8.522B |
| Alnylam Pharmaceuticals, Inc. | 34.18B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8284M |
| Total Expenses (Quarterly) | 0.8284M |
| EPS Diluted (Quarterly) | -0.2355 |